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Abstract 
Disruption to sleep and circadian rhythms can impact on metabolism. The study aimed to 
investigate the effect of acute sleep deprivation on plasma melatonin, cortisol and 
metabolites, to increase understanding of the metabolic pathways involved in sleep/wake 
regulation processes. Twelve healthy young female subjects remained in controlled 
laboratory conditions for ~92 h with respect to posture, meals and environment light 
(18:00-23:00 h and 07:00-09:00 h <8 lux; 23:00-07:00 h 0 lux (sleep opportunity) or <8 lux 
(continuous wakefulness); 09:00-18:00 h ~ 90 lux). Regular blood samples were collected for 
70 h for plasma melatonin and cortisol, and targeted liquid chromatography-mass 
spectrometry metabolomics. Timepoints between 00:00 and 06:00 h for day 1 (baseline 
sleep), day 2 (sleep deprivation) and day 3 (recovery sleep) were analysed. Cosinor analysis 
and MetaCycle analysis were performed for detection of rhythmicity. Night time melatonin 
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levels were significantly increased during sleep deprivation and returned to baseline levels 
during recovery sleep. No significant differences were observed in cortisol levels. Of 130 
plasma metabolites quantified, 41 metabolites were significantly altered across the study 
nights, with the majority decreasing during sleep deprivation, most notably 
phosphatidylcholines. In cosinor analysis, 58 metabolites maintained their rhythmicity across 
the study days, with the majority showing a phase advance during acute sleep deprivation. 
This observation differs to that previously reported for males. Our study is the first of 
metabolic profiling in females during sleep deprivation and recovery sleep, and offers a novel 
view of human sleep/wake regulation and sex differences. 
 
Introduction 
 Sleep comprises approximately one-third of our lifetime and is an essential 
physiological function indispensable for survival. In our 24/7 lifestyle of modern society sleep 
duration has been significantly reduced and more people experience insufficient sleep (Deng 
et al., 2017). Sleep deprivation has been shown to impact metabolism and immune systems, 
leading to increased incidence of obesity, impaired glucose tolerance, metabolic syndrome 
and cardiovascular disease (Spiegel et al., 2005; Scheer et al., 2009; Huang et al., 2011; 
Johnston, 2014). 
 Circadian clocks control the timing of most daily biological processes, behaviour 
and activity, including changes in metabolism and the sleep/wake cycle (Hastings et al., 
2003; Mohawk et al., 2012). The master clock, located in the hypothalamic suprachiasmatic 
nuclei (SCN), is entrained to the external light-dark cycle by photic signals transmitted via the 
retinohypothalamic tract, and coordinates timing of peripheral clocks distributed throughout 
the body (Reppert & Weaver, 2002; Barclay et al., 2012). Melatonin and cortisol show robust 
circadian rhythms driven by the SCN oscillator (Czeisler et al., 1999; Gunn et al., 2016), and 
melatonin is considered a reliable marker of the master clock (Klerman et al., 2002). In 
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entrained conditions, melatonin levels rise in the evening hours, peak in the early hours of the 
morning, and return to basal levels soon after waking (Arendt, 1988).  
 
 Liquid chromatography–mass spectrometry (LC/MS) metabolomics analysis has 
been employed widely to identify and quantify hundreds of metabolites in complex biological 
matrices such as blood, urine and saliva. Robust circadian rhythms in rodent (Minami et al., 
2009; Eckel-Mahan et al., 2012) and human metabolites have been identified under constant 
routine conditions (Dallmann et al., 2012; Kasukawa et al., 2012; Skene et al., 2018). 
Dallmann et al. (2012) reported that 15% of the metabolites quantified in human plasma and 
saliva showed circadian variation, particularly amino acids in saliva and fatty acids in plasma. 
Previously, we reported a significant time of day variation in 64% of the metabolites 
measured in healthy young men kept under a controlled light/dark conditions (Davies et al., 
2014). In spite of numerous studies on sex differences in metabolic profiling (Mittelstrass et 
al., 2011; Ruoppolo et al., 2014; Rist et al., 2017), surprisingly little is known about the effect 
of sleep deprivation on metabolite profiles in females. As the composition of metabolites is 
different between males and females (Pitkanen et al., 2003; Mittelstrass et al., 2011; 
Ruoppolo et al., 2014), the sex-based differences in metabolite rhythms are of great interest. 
The aim of this study was to assess the timing, amplitude and phase relationship of the 
SCN-driven hormone rhythms (melatonin and cortisol) and plasma metabolite rhythms with a 
sleep/wake cycle, during 24 h of wakefulness and a recovery sleep in healthy young females. 
Assessing the effect of acute sleep deprivation on circulating metabolites and their rhythms 
may lead to increased understanding of the metabolic pathways involved in sleep/wake 
regulation and development of sleep biomarkers.  
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Materials and Methods 
Clinical study. Laboratory sessions were conducted at the Surrey Clinical Research Centre 
(SCRC) at the University of Surrey. Ethical approval for the study was given by the University 
of Surrey Ethics Committee. All participants provided written informed consent prior to any 
procedures being performed and participants were allowed to withdraw at any time. All 
participant information was coded and held in strictest confidence according to the Data 
Protection Act (UK, 1998). The initial screening phase including eligibility criteria has been 
reported previously (Ackermann et al., 2012). Briefly, study eligibility was determined by 
questionnaires including Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness scale 
(ESS), Horne-Östberg (H-O) and Beck Depression Index (BDI), medical and physical 
assessment, and analysis of blood and urine samples. The participants did not report sleep 
problems (PSQI score ≤ 5), depression (BDI < 10), daytime sleepiness (ESS < 11) and were 
not extreme morning or evening types (30 < H-O < 70). 
Healthy females (n = 12; aged: 25 ± 4 yrs, mean ± SD) with a BMI of 24.9 ± 3.6 
kg/m2 (mean ± SD) were enrolled into the study. All were non-smokers and unmedicated 
except that they were taking combined oral contraceptives and were on the active phase 
during the laboratory session. None had a history of shift work or travel across two or more 
time zones in the preceding month. Prior to the in-laboratory session, participants maintained 
a regular sleep/wake schedule (23:00 – 07:00 h) at home for 10 days (confirmed by wrist 
actigraphy (Actiwatch-L, Cambridge Neurotechnology Ltd., UK) and sleep diaries). They 
were also required to have exposure to outdoor light each morning for at least 15 min 
between 07:00 and 08:30 h. For 72 h before the in-laboratory session, participants were 
requested to abstain from alcohol, caffeine and strenuous exercise. This baseline-at-home 
period minimised exogenous confounding factors, stabilised circadian phase and ensured 
participants were not sleep deprived prior to the study.  
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In-Laboratory Session. Participants entered the laboratory at 16:00 h on day 0 and 
remained until 12:00 h on day 4 in a controlled environment with regards to environmental 
light, sleep, and meals, with an adaptation night (day 0) followed by an 8 h sleep opportunity 
(23:00 – 07:00 h) on day 1 (baseline sleep), total sleep deprivation on day 2 (sleep 
deprivation), and an 8 h recovery sleep opportunity on day 3 (recovery sleep). Participants 
remained in <8 lux between 18:00 and 23:00 h, and between 07:00 and 09:00 h each day. On 
days 0, 1 and 3 participants slept between 23:00 and 07:00 h (0 lux), and remained awake 
during this time in <8 lux on day 2. Between 09:00 and 18:00 h each day participants were 
free to move about in normal room lighting (~ 90 lux). The same standardised meals were 
given on each day of the study at 07:00, 13:00, and 19:00 h with a snack at 22:00 h. Blood 
samples were collected for 70 h at 2 hourly intervals for metabolomics analysis and at 1 – 2 
hourly intervals for hormone assays (12:00 h on day 1 – 10:00 h on day 4). Plasma fractions 
for metabolomics analysis were stored at -80°C until derivatisation, plasma for hormone 
assays were stored at -20°C until analysis. A detailed scheme of the study protocol is shown 
in Supplementary Figure S1. 
 
Sample Analysis. Plasma melatonin and cortisol concentrations were measured by 
radioimmunoassay (Stockgrand Ltd., University of Surrey) as described previously (Sletten et 
al., 2009). Targeted liquid chromatography-mass spectrometry (LC/MS) was performed on 
two-hourly plasma samples to identify and quantify metabolite concentrations, using the 
AbsoluteIDQ p180 targeted metabolomics kit (Biocrates Life Sciences AG, Innsbruck, 
Austria), and a Waters Xevo TQ-S mass spectrometer coupled to an Acquity UPLC system 
(Waters Corporation, Milford, MA, USA) as previously described (Davies et al., 2014; 
Isherwood et al., 2017; Skene et al., 2017). The kit provides absolute concentrations of 184 
metabolites from 6 different compound classes (acylcarnitines, amino acids, biogenic 
amines, lysophosphatidylcholines, glycerophospholipids and sphingolipids). Plasma samples 
were prepared according to the manufacturer’s instructions. Sample order was randomised 
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and three levels of quality controls (QC), run on each 96-well plate. Data were normalised 
between batches using the quality control level 2 (QC2) repeats across each plate (n = 4) and 
between plates (n = 5) using Biocrates METIDQ software (QC2 correction). Metabolites 
where >25% concentrations were below the limit of detection (<LOD) or below lower limit of 
quantification (≪LLOQ) or above limit of quantification (>LOQ) or blank out of range, or the 
QC2 coefficient of variance was > 30%, were excluded (n = 54).  
 
Data Analysis. Dim light melatonin onset (DLMO) for separate study days was calculated for 
each participant using the 25% threshold method as previously described (Sletten et al., 
2009). Night time melatonin levels (00:00 – 06:00 h) were compared between the study 
nights using two-way repeated ANOVA (R version 6.3.2). Significant p-values were adjusted 
for multiple comparisons according to the Benjamini-Hochberg false discovery rate (FDR) 
(Benjamini & Hochberg, 1995). Principal component analysis (PCA) and orthogonal partial 
least squares discriminant analysis (OPLS-DA) were performed using SIMCA-P v.13.0 
software (Umetrics, Malmo, Sweden) to visualise the overall variation and components 
clustering between study days. To examine metabolite levels during the night time sleep 
periods (00:00 – 06:00 h), a two-way repeated ANOVA was carried out (R6.3.2). To assess 
24 h metabolite rhythmicity, cosinor analysis was performed on the mean z-score values of 
each study day (12:00 – 10:00) for each metabolite profile using MATLAB and Bioinformatics 
Toolbox Release 2016a (The MathWorks, Inc., Natick, Massachusetts, USA). Peak time 
(acrophase), amplitude, and significance of a cosine fit (p < 0.05) were determined for each 
metabolite. Rhythmicity was also assessed using MetaCycle software (Glynn et al., 2006; 
Hughes et al., 2010) with R6.3.2 which provided acrophase, amplitude, relative amplitude 
value (FDR adjusted p-value < 0.05). All data are shown as mean ± SEM. 
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RESULTS 
Hormone rhythms. Night-time melatonin levels (00:00 – 06:00 h) showed a significant 
increase during sleep deprivation relative to baseline sleep (19 ± 7%), these levels declining 
back to baseline during recovery sleep (day 1 sleep, 84.8 ± 8.0 pg/ml; day 2 sleep 
deprivation, 102.1 ± 5.6 pg/ml; day 3 recovery sleep, 81.5 ± 4.2 pg/ml; FDR adjusted p < 
0.001; Figure 1A). On day 1 the DLMO was 21:56 ± 0:14 h and this did not change 
significantly between study days (day 2, 22:02 ± 0:14 h; day 3, 21:54 ± 0:11 h). No significant 
differences were observed in the peak night time cortisol levels between the study days (day 
1, 268 ± 62 nmol/L; day 2, 309 ± 67 nmol/L; day 3, 287 ± 51 nmol/L; Figure 1B). 
 
Multivariate analysis of metabolites. A total of 130 metabolites were detected by targeted 
LC/MS metabolomics, grouped into amino acids (n = 19), acylcarnitines (n = 10), biogenic 
amines (n = 7), glycerophospholipids (n = 80) and sphingolipids (n = 14). Principal 
component analysis (PCA) of all the data showed there was clear time-of-day variation in 
principal component (PC)1 (amount of variance in the x matrix explained by PC1 (R2) = 
0.367, estimate of the predictive ability of the model (Q2) (cumulative) = 0.358) with the mean 
score on PC1 having a significant fit to a cosine curve across the study days (acrophase: 
15:31 h, 14:04 h, 15:20 h; amplitude: 2.14, 2.18, 1.99, day1, 2, 3, respectively) (Figure 2). 
OPLS-DA models, validated by permutation analysis and a CV ANOVA p value of the model, 
showed clear separation between sleep (00:00 – 06:00 h, day 1) and sleep deprivation 
(00:00–06:00 h, day 2); Q2 (cumulative) = 0.641, R2X (cumulative) = 0.707, R2Y (cumulative) 
= 0.903 (Figure 3A), between sleep (00:00–06:00 h, day 1) and recovery sleep (00:00–06:00 
h, day 3); Q2 (cumulative) = 0.608, R2X (cumulative) = 0.601, R2Y (cumulative) = 0.790, and 
between sleep deprivation (00:00–06:00 h, day 2) and recovery sleep (00:00–06:00 h, day 3) 
(Figure 3B); Q2 (cumulative) = 0.439, R2X (cumulative) = 0.592, R2Y (cumulative) = 0.722 
(Supplementary Figure S2A). The p(corr) loading plot for the OPLS-DA models are shown in 
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Figure 3C, D and Supplementary Figure S2B; metabolites with negative values decreased in 
sleep deprivation and metabolites with positive values increased in sleep deprivation. Plasma 
levels of histidine, glutamate, glutamine, lysine, carnitine, symmetric dimethylarginine 
(SDMA) and 6 glycerophospholipids (lysoPC a C18:0, PC aa C36:5, PC aa C40:3, PC aa 
C42:2, PC ae C36:3, and PC ae C42:2) decreased during sleep deprivation and 
tetradecenoylcarnitine, taurine, methionine levels increased during sleep deprivation 
(|p(corr)| >0.15) (Supplementary Table S1).  
 
Univariate analysis of metabolites. Of the 130 metabolites, 41 (32%) metabolites showed 
significant differences in their night time concentrations (0:00 – 6:00 h) in the study days 
(FDR adjusted p < 0.05); 12 (of 19) amino acids (threonine, glycine, alanine, glutamate, 
glutamine, histidine, lysine, asparagine, ornithine, methionine, arginine and proline), 
carnitine, 2 biogenic amines (taurine, SDMA), 25 (of 80) glycerophospholipids (lysoPC a 
C18:0, PC aa C36:1, PC aa C36:5, PC aa C38:0, PC aa C38:5, PC aa C40:2, PC aa C40:3, 
PC aa C40:4, PC aa C40:5, PC aa C40:6, PC aa C42:2, PC aa C42:6, PC ae C34:2, PC ae 
C34:3, PC ae C36:0, PC ae C36:3, PC ae C36:4, PC ae C36:5, PC ae C38:0, PC ae C38:5, 
PC ae C38:6, PC ae C40:1, PC ae C42:1, PC ae C42:2 and PC ae C42:4) and 1 (of 14) 
sphingolipid (SM C20:2) (Supplementary Table S2). Only 15 out of 130 metabolites (12%) 
were significantly different between the sleep and sleep-deprivation periods, 5 amino acids 
(histidine, glutamate, threonine, lysine, citrulline), carnitine, SDMA, lysoPC a C18:0 and 7 
phosphatidylcholines. Except threonine, all of these metabolites exhibited decreased levels 
during sleep deprivation compared to baseline sleep. Of these, 7 metabolites showed a 
significant difference between sleep deprivation and recovery sleep; histidine, lysine, 
citrulline, carnitine and SDMA returned to baseline levels, 2 phosphatidylcholines (PC aa 
C36:5 and PC ae C42:2) showed a further decrease and threonine showed a further increase 
during recovery sleep (Supplementary Table S3). 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Daily rhythms in metabolites. To assess rhythmic variation of the metabolites, cosinor 
analysis of the mean z-score metabolite profiles on each study day was performed. Of the 
130 metabolites, 33 (25%) metabolites showed no rhythmicity across any of the study days 
(Figure 4A). Of the 97 remaining metabolites, significant daily rhythms were observed in 78 
(60%) metabolites; 3 amino acids (asparagine, glutamate, glycine), valeryl-carnitine, 4 
biogenic amines (alpha-Aminoadipic acid (alpha-AAA), kynurenine, SDMA, 
trans-4-Hydroxyproline (t4-OH-Pro)), 60 glycerophospholipids and 10 sphingolipids, with 
most metabolites (n = 63; 81%) peaking during the day (06:00–18:00 h). Of these, 62 (79%) 
metabolites maintained their rhythmicity during sleep deprivation, with 58 (74%) maintaining 
their rhythmicity across all 3 study days. Metabolites (n = 58) showing daily rhythms across 
all 3 study days included 2 amino acids (asparagine, glutamate), one acylcarnitine 
(valerylcarnitine), 2 biogenic amines (SDMA, t4-OH-Pro), 46 glycerophospholipids and 7 
sphingolipids (Figure 4B). Of these, the majority (n = 56; 97%), except valerylarnitine and 
SDMA, showed an advanced acrophase during sleep deprivation (-1.6 ± 0.1 h), with the 
majority (n = 49; 88%) subsequently returning to baseline timing during recovery sleep 
(Supplementary Table S4). Metabolite data were also analysed with MetaCycle 
(JTK-CYCLE). Using this analysis significant daily rhythms were observed in only 18% (n=23) 
of metabolites on day 1 (normal sleep/wake); namely 2 amino acids (glutamate, glycine), 2 
biogenic amines (SDMA, t4-OH-Pro), and 19 glycerophospholipids. Of these, 12 (52%) 
metabolites maintained rhythmicity on day 2 (sleep deprivation) and only 8 (35%) metabolites 
maintained rhythmicity across the 3 study days; t4-OH-Pro and 7 glycerophospholipids 
(Supplementary Figure S3, Supplementary Table S5).  
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Sex differences 
 In our previous study diurnal rhythms in plasma metabolites in young males were 
also observed (Davies et al., 2014). Reanalysing these data using the same criteria as for the 
female data as described in the Methods above (Isherwood et al., 2017; Skene et al., 2017), 
141 metabolites were quantified. Of these, 77 (55%) exhibited a daily rhythm that had a 
significant fit to a cosine curve on day 1 (sleep) with most (n = 53; 69%) maintaining their 24 h 
rhythmicity on day 2 (sleep deprivation). Of these, the majority (n = 45; 85%) showed a delay 
in acrophase time during sleep deprivation (1.4 ± 0.2 h) (Supplementary Table S6). The 
mean score on PC1 had a significant fit to a cosine curve on day 1 with an acrophase of 
14:47 h, but no significant fit on day 2 (15:50 h, p=0.053) (Supplementary Figure S4). In a 
subset analysis of both sexes, there were 32 common metabolites that exhibited diurnal 
rhythms on day 1 and day 2. The mean acrophase time of these metabolites was significantly 
later in the female group on day 1 (15:48 ± 0:40 h) compared to the male group (14:53 ± 0:42 
h, p<0.001, Student’s T-test), and earlier on day 2 (14:29 ± 0:38 h) compared to males (16:52 
± 0:38 h, p<0.001, Student’s T-test) (Figure 5, Supplementary Table S7), although no 
significant difference in DLMO (female: 21:56 ± 0:14 h, male: 21:58 ± 0:31 h) was observed. 
Metabolites that were only rhythmic on day 1 and day 2 in females (n = 13) and only rhythmic 
in males (n = 15) are also presented in Supplementary Table S7. 
  Sex differences in the metabolites affected by sleep deprivation were also observed 
(Supplementary Table S8). In females, 15 (12%) of the 130 metabolites were significantly 
altered during sleep deprivation, all but threonine showing decreased levels. By contrast, in 
the males 37 out of 141 metabolites (26%) exhibited significant changes during sleep 
deprivation, all increasing during sleep deprivation.  
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
DISCUSSION 
 This study aimed to assess the effect of a single night of total sleep deprivation 
followed by recovery sleep under controlled laboratory conditions on both biomarkers of the 
central circadian pacemaker and plasma metabolic profiles in young females. 
 The pineal hormone melatonin showed significantly increased plasma 
concentrations during sleep deprivation, which is in agreement with our previous study in 
young males (Ackermann et al., 2013; Davies et al., 2014), and returned to baseline levels 
during a subsequent night of recovery sleep. Although the mechanism underlying this 
increase is not known, we previously showed induction of a heat shock protein coding gene 
HSPA1B expression during sleep deprivation (Ackermann et al., 2012), suggesting a direct 
consequence of the oxidative stress induced by sleep loss, which may lead to up-regulation 
of melatonin, a well-known antioxidant (Reiter et al., 2000; Carrillo-Vico et al., 2005).  
 Increased melatonin levels during sleep deprivation might also reflect increased 
adrenergic stimulation (Klein & Weller, 1973; Skene et al., 1994). Sleep deprivation may also 
act directly on SCN neuronal activity reducing SCN output (Deboer et al., 2007) that, in turn, 
may activate melatonin synthesis via the SCN-pineal multi-synaptic pathway. Whilst we 
assume that the increased plasma levels arise from the pineal gland, there is also the 
possibility that the melatonin is derived from the gastrointestinal tract (GIT). The amount of 
melatonin in the GIT is estimated to be more than 400 times that of the pineal gland (Huether, 
1993). There is some evidence that food deprivation and fasting increases melatonin levels in 
the brain and GIT of mice (Bubenik et al., 1992) and in the serum of humans (Beitins et al., 
1985). It can be speculated that the increased energy expenditure and fasting during sleep 
deprivation may induce melatonin release from the GIT into the circulation. 
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 In our study, only 15 metabolites levels were significantly different between the 
sleep and sleep-deprivation periods: histidine, glutamate, threonine, lysine, citrulline, 
carnitine, SDMA, lysoPC a C18:0 and 7 phosphatidylcholines. Apart from threonine, all of 
these metabolites exhibited decreased levels during sleep deprivation. Both during the sleep 
period and during sleep deprivation, the participants were in a fasting state. Thus the 
metabolites that changed during sleep deprivation were not a direct effect of fasting. 
However, the interaction of increased energy consumption during the sleep deprivation 
period and the fasting state may contribute to the observed metabolite differences. 
 L-Histidine is an essential amino acid that is a precursor to histamine. Being able to 
cross the blood brain barrier (Hargreaves & Pardridge, 1988), histidine levels in the blood 
may reflect brain histamine levels and histaminergic neuronal activity in the 
tuberomammillary nucleus, where they play a critical role in the maintenance of arousal 
(Saper et al., 2010). The observed reduction of blood histidine levels during sleep deprivation 
may reflect its increased degradation into histamine as an acute response to sleep loss, 
returning to baseline levels during recovery sleep. Glutamate is the most abundant excitatory 
neurotransmitter in the vertebrate nervous system (Meldrum, 2000) and also serves as the 
precursor for the synthesis of the inhibitory gamma-aminobutyric acid (GABA) in GABAergic 
neurons, which plays an important role in the sleep promoting systems in the brain (Sherin et 
al., 1996; Gallopin et al., 2000). Glutamine is the most abundant free amino acid in blood, 
making a large contribution to cellular respiration as an energy source following glucose and 
lactate (Hui et al., 2017). Glutamate and glutamine play important roles in removing excess 
nitrogen, detoxifying ammonia in the skeletal muscle, brain, kidney and liver (Adeva et al., 
2012). In our study, plasma glutamate decreased during sleep deprivation and did not return 
to baseline levels during recovery sleep. Glutamine also showed a trend to decrease during 
sleep deprivation, returning to baseline levels during recovery sleep. These results can be 
attributed to increased energy demands and increased need for removal of metabolic waste 
products from the brain during sleep deprivation (Xie et al., 2013). Diurnal changes in brain 
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glutamate and glutamine levels were recently observed in healthy young adults with a 
significant overnight reduction assessed by proton magnetic resonance spectroscopy (Volk 
et al., 2018). In addition, a previous study reported reduced glutamine levels associated with 
lower total sleep time and increased wake-time after sleep onset (Miller et al., 2017), 
supporting our hypothesis. 
 Carnitine plays an important role in energy production by conjugating fatty acids for 
transport into the mitochondria, by forming a long chain acetylcarnitine ester (Rebouche, 
2004). Several reports have indicated a role for fatty acid β- oxidation and the carnitine 
system in sleep/wake regulation. However, the role of carnitine and acylcarnitine in the brain 
remains unknown. Fasting in systemic carnitine deficient juvenile visceral steatosis (jvs-/-) 
mice exhibited a higher frequency of fragmented wakefulness and rapid-eye movement 
(REM) sleep, and reduced locomotor activity (Yoshida et al., 2006). In these mice, a lower 
percentage of c-Fos positive orexin neurons, which regulate the sleep/wake cycle and food 
intake, and reduced orexin-A concentration in the cerebrospinal fluid was observed (Yoshida 
et al., 2006). It has been reported that supplementation of acetylcarnitine produces 
releasable glutamate (Toth et al., 1993; Tanaka et al., 2003). Orexin producing cells in the 
lateral hypothalamus are mainly innervated by excitatory neurons containing glutamate (Li et 
al., 2002; Horvath & Gao, 2005). These findings indicate that acylcarnitine availability is 
essential for normal sleep/wake regulation and orexin cell functions. Thus, our results 
suggest increased acylcarnitine consumption during sleep deprivation to maintain 
wakefulness via the orexinergic arousal system. 
 Previous studies have indicated that cholesterol/lipid metabolism is regulated by 
the sleep/wake cycle and that sleep deprivation may modify it (Jones et al., 2008; 
Moller-Levet et al., 2013). Detailed characterisation of lipid profiles, however, has remained 
unclear. In our previous study using LC/MS analysis, increases in blood glycerophospholipids 
levels were observed during the acute sleep deprivation period (Davies et al., 2014). 
Elevated phospholipids were also reported after sleep deprivation in the rat and human 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
(Weljie et al., 2015). Another study with MS-based lipidomic analysis showed increased 
levels of lipids following sleep restriction (five nights of 4 h/night in bed) compared to controls 
(8 h in bed) (Aho et al., 2016). These authors reported that sleep loss decreased the 
expression of genes encoding cholesterol transporters by activating inflammatory responses 
(Aho et al., 2016). Toll-like receptors suppress the activity of liver X receptor (LXR) regulating 
cholesterol metabolism (Castrillo et al., 2003; Choi et al., 2015)), which leads to decreased 
reverse cholesterol transport and synthesis of fatty acids and triglycerides (Joseph et al., 
2003; Lee & Tontonoz, 2015). These findings suggest that sleep deprivation/restriction 
modifies cholesterol pathways at the level of gene expression and serum lipoproteins. 
 SDMA is reported to be an endogenous marker of renal function (Kielstein et al., 
2006) and is negatively associated with nitric oxide (NO) production (Bode-Boger et al., 
2006). As NO is reported to regulate the sleep/wake state via inactivation of orexin neurons 
(Cespuglio et al., 2012; Yamakawa et al., 2018), a reduction in plasma SDMA could be 
related to the disruption of sleep homeostasis during the study.  
Previous studies have suggested that amino acid and fatty acid metabolism is under 
circadian control (Blanco et al., 2007; Bray & Young, 2011; Huang et al., 2011). Reverse-erb 
alpha (REV-ERBα), a circadian transcription gene encoding the nuclear orphan receptor, 
regulates hepatic gluconeogenesis, adipocyte differentiation, and lipid metabolism (Duez & 
Staels, 2008). REV-ERBα also controls oscillations in sterol regulatory element-binding 
protein (SREBP) activity, through modulation of insulin-induced gene 2, a resident protein of 
the endoplasmic reticulum, and thereby in the daily expression of SREBP target genes 
involved in cholesterol and lipid metabolism (Le Martelot et al., 2009). These authors reported 
that alteration of oxysterol synthesis and LXR activity mediated the effects of REV-ERBα on 
bile acid metabolism.  
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Metabolomics and lipidomics studies have analysed plasma samples from 
participants kept under constant routine laboratory conditions and found that 15% of all 
identified metabolites, most notably fatty acids (Dallmann et al., 2012) and 13% of lipid 
metabolites (Chua et al., 2013) were under circadian clock control suggesting a direct effect 
of circadian timing on fatty acid metabolism. We ourselves have seen 33% rhythmic 
glycerophospholipids under constant routine conditions following a simulated day shift 
(Skene et al., 2018) supporting this hypothesis. In the current study, of the 130 metabolites 
identified, the largest group of compounds exhibiting diurnal variation across the 3 study 
days, was lipids (n=46 with cosinor analysis and n=7 with MetaCycle analysis), implying a 
robust circadian timing system underlying the daily rhythms in lipid metabolites. The peak 
phases of rhythmic phosphatidylcholines and sphingolipids mostly occurred in the day time 
(15:35 ± 0:14 h, n = 60) which is consistent with previous reports (Ang et al., 2012; Dallmann 
et al., 2012; Davies et al., 2014). Interestingly, most metabolites (n=56, 97% with cosinor 
analysis and n=6, 75% with MetaCycle analysis) maintaining rhythmicity across the 3 study 
days showed a tendency to phase advance during the 24 h of wakefulness, most notably the 
glycerophospholipids, with the majority returning to baseline timings during the subsequent 
recovery sleep. Besides the circadian timing system, the behavioural state (e.g. 
feeding/fasting, sleep/wakefulness, postural changes) may affect the 24 h rhythmicity of 
metabolites. Currently we are unable to say which of these behaviours contribute most to the 
observed metabolite rhythmicity. Further systematic experiments are needed to accurately 
assess the contribution of each. 
Recently, sleep restriction was reported to affect circadian rhythmicity of the rodent 
and human transcriptome (Barclay et al., 2012; Moller-Levet et al., 2013). Employing 
transcriptome analysis of human blood,  ller-Levet et al. (2013) reported that the number of 
genes whose transcripts had circadian expression were reduced in sleep restriction. 
Moreover, during the sleep restriction condition, those genes with peak times during the 
biological night had later peak times, and genes with peak times in the biological day had 
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earlier peak times. The peak phases of rhythmic metabolites likely relate to the physiologic 
pathways in which they are involved. For example, the fat clock promotes lipogenesis and 
adiponectin production during the wake period (Bass & Takahashi, 2010), which is consistent 
with our data of most phospholipids peaking during the day.  
We performed two distinct analyses for assessing the daily rhythmicity of 
metabolites: cosinor analysis and MetaCycle. The methods showed large differences in the 
number of rhythmic metabolites, one possible reason being that MetaCycle performed FDR 
correction of the p-values. Thus, the data analysed using MetaCycle were more strictly 
selected, comprising a subset of metabolites which also showed statistical significance with 
cosinor analysis.  
 To our knowledge, this is the first report of metabolic profiling during acute total 
sleep deprivation and recovery sleep conditions in females. Taking data from our previous 
study of healthy young males (Davies et al., 2014) and reanalysing with the same criteria as 
the current female study, 37 out of 141 (26%) detected metabolites exhibited significant 
changes during sleep deprivation compared with during sleep, including tryptophan, 
serotonin, taurine, 6 acylcarnitines, 24 glycerophospholipids and 4 sphingolipids. All of these 
metabolites exhibited increased levels during sleep deprivation. By contrast, in the current 
female study, only 12% (n = 15) of the 130 identified metabolites exhibited significant 
changes and most of these (n = 14, 93%) exhibited decreased levels during sleep 
deprivation. Although the same study protocol, research facilities and analytical methodology 
was used, the differences between the two studies are striking. Although previous studies 
have suggested that men and women, and male and female rodents respond differently to 
sleep deprivation (Acheson et al., 2007; Ferrara et al., 2015; Baratta et al., 2018), until now 
its effect on circulating metabolite profiles have not been investigated.  
 Sex differences in plasma metabolites have been reported with most studies 
showing higher levels of amino acids and acylcarnitine in males compared to females 
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(Pitkanen et al., 2003; Mittelstrass et al., 2011; Ruoppolo et al., 2014). In addition, the use of 
oral contraceptives, as used in the current study, induces specific alterations in the serum 
metabolic status (Ruoppolo et al., 2014). The levels of phosphatidylcholines and 
sphingolipids show a tendency to be higher in females, supporting an increase in lipid storage 
rather than metabolism in females (Mittelstrass et al., 2011; Rist et al., 2017). 
 Sleep disruption can affect peripheral clocks, where each tissue keeps metabolic 
processes in synchrony (Bass & Takahashi, 2010). As the utilization of energy and metabolic 
rate are different between genders (Arciero et al., 1993; Volpi et al., 1998), the timing of 
metabolite rhythms and their alternation during sleep deprivation may vary between the 
sexes.  
 DLMO has been reported to be significantly earlier in females than males 
(Mongrain et al., 2004; Cain et al., 2010; Van Reen et al., 2013), but there was no difference 
observed in our study. Gunn et al. (2016) demonstrated females exhibited significantly 
greater levels of plasma melatonin and cortisol than males during a constant routine protocol. 
Our previous male study also demonstrated increased night time melatonin levels during 
sleep deprivation (Davies et al., 2014), but the increase was greater in males than females 
(27 ± 5%, 19 ± 7%, respectively), suggesting a sex difference in reaction to sleep 
loss/wakefulness. In addition, alteration in blood melatonin levels can affect metabolic profiles 
(Dubocovich & Markowska, 2005; Bass & Takahashi, 2010), which may relate to different 
trends (increase/decrease) in metabolite concentrations during sleep deprivation between 
males and females. Female rodents are reported to have shorter circadian periods than 
males (Davis et al., 1983; Schull et al., 1989), and in a human study under laboratory 
conditions to detect intrinsic circadian period (Duffy et al., 2011) females indeed had a shorter 
tau. Our data showed the mean acrophase of common metabolites occurred significantly 
later in females, which then advanced to earlier than that of males during sleep deprivation. 
This tendency was also observed in the acrophase of the mean score on PC1 of all 
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metabolites; with an advance during sleep deprivation in females but a delay in males (Figure 
2 and Supplementary Figure S4).  
In the current study the effect of the menstrual cycle was controlled for by only including 
women on hormonal contraceptives. In follow up studies it will be important to investigate 
how these metabolites vary across the menstrual cycle (follicular and luteal phases) and 
whether this is affected by sleep deprivation. 
 In conclusion, in this first report of metabolic profiling during sleep deprivation and 
recovery sleep in females, we have identified a panel of plasma metabolites that are 
significantly altered during acute sleep deprivation and recovery sleep. There appear to be 
some differences between males and females in the response to sleep deprivation but, as 
yet, the underlying basis of these cannot be fully explained. These findings will be useful in 
guiding the design and interpretation of future metabolite-based studies from the point of sex 
differences. 
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GABA: gamma-aminobutyric acid 
GIT: gastrointestinal tract 
LC/MS: Liquid chromatography–mass spectrometry 
LLOQ: lower limit of quantification 
LOD: limit of detection 
LOQ: limit of quantification 
LXR: liver X receptor 
lysoPC: lysophosphatidylcholine 
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Figure Captions 
Figure 1. Mean (± SEM) plasma hormone concentrations (n = 12) over the 70-h sampling 
protocol (A, melatonin; B, cortisol). The black bar indicates the sleep period, 0 lux, supine; 
grey bars, wake periods, semi-recumbent position, <8 lux; white bars, awake and free 
movement, 90 lux. 
 
Figure 2. PCA of all metabolites data were carried out, and the significant time-of-day 
variation in mean score (± SEM) across all subjects on PC1 is shown. The black bar indicates 
the sleep period, 0 lux, supine; grey bars, wake periods, semi-recumbent position, <8 lux; 
white bars, awake and free movement, 90 lux. 
 
Figure 3. OPLS-DA models of selected time points (00:00–06:00 h) separated according to 
sleep status (A, day 1, sleep (black circle) vs. day 2, sleep deprivation (red circle); B, day 1, 
sleep (black circle) vs. day 3, recovery sleep (blue circle)). Loading plots for the OPLS-DA 
models (C, day 1, sleep vs. day 2, sleep deprivation; D, day 1, sleep vs. day 3, recovery 
sleep) coloured according to class; amino acids and biogenic amines (blue), acylcarnitines 
(green), glycerophospholipids (PC aa (yellow), PC ae (light orange), lysoPC (dark orange)) 
and sphingolipids (brown). Positive P (loading) values represent metabolites with higher 
concentrations, and negative P (loading) values represent metabolites with lower 
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concentrations during sleep deprivation (C) and recovery sleep (D) compared with sleep. For 
lists of metabolites and their corresponding P (loading) values, see Supplementary Table S1. 
 
Figure 4. Metabolites with a significant cosine rhythm during the 3 study days. (A) Venn 
diagram showing the number of metabolites exhibiting a significant fit to a cosine curve on 
day 1 (sleep, grey circle), day 2 (sleep deprivation, red circle), day 3 (recovery sleep, blue 
circle). (B) Pie charts showing the proportion of metabolites from each metabolite class 
exhibiting a significant fit to a cosine curve all days. 
 
Figure 5. Peak times (acrophase) of 31 common metabolites with a significant fit to a cosine 
curve in both males and females on day 1 (black circle) and day 2 (red circle). Dim light 
melatonin onset (DLMO) times on both days (day 1: black triangle, day 2: red triangle) are 
shown. Labelled metabolites had a difference in acrophase time of 4 hours or more between 
males and females. For the details of metabolite acrophase times, see Supplementary Table 
S7. 
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